|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| OPERATING EXPENSES: | |||||
| Cost of revenue | |||||
| Research and development | |||||
| Sales, general and administrative | |||||
| Total operating expenses | |||||
| Total costs and expenses | |||||
| Loss from operations | |||||
| Other income (expense), net: | |||||
| Interest expense (related party) | |||||
| Interest and other income, net | |||||
| Other income (expense), net | |||||
| Net loss and total comprehensive loss | |||||
| Total comprehensive loss | |||||
| Cumulative dividends on Series A preferred stock | |||||
| Net loss - attributed to common stockholders | |||||
| Net loss per share, basic (in Dollars per share) | |||||
| Net loss per share, diluted (in Dollars per share) | |||||
| Weighted average shares used in computing net loss per share, basic (in Shares) | |||||
| Weighted average shares used in computing net loss per share, diluted (in Shares) | |||||
Loading...